UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives

Liver international, 2016-01, Vol.36 (S1), p.47-57

2016

Volltextzugriff (PDF)

Targets and future direct-acting antiviral approaches to achieve hepatitis B virus cure

The lancet. Gastroenterology & hepatology, 2019-11, Vol.4 (11), p.883-892

2019

Volltextzugriff (PDF)

Fibrosis and disease progression in hepatitis C

Hepatology (Baltimore, Md.), 2002-11, Vol.36, p.s47-s56

2002

Volltextzugriff (PDF)

Potential of SAR sensors TerraSAR-X, ASAR/ENVISAT and PALSAR/ALOS for monitoring sugarcane crops on Reunion Island

Remote sensing of environment, 2009-08, Vol.113 (8), p.1724-1738

2009

Volltextzugriff (PDF)

Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa‐2a in HBeAg‐negative patients

Hepatology (Baltimore, Md.), 2009-04, Vol.49 (4), p.1151-1157

2009

Volltextzugriff (PDF)

Eradication of Hepatitis C Virus in Patients Successfully Treated for Chronic Hepatitis C

Gastroenterology (New York, N.Y. 1943), 2008-09, Vol.135 (3), p.821-829

2008

Volltextzugriff (PDF)

High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: A long-term follow-up study

Journal of hepatology, 2009-06, Vol.50 (6), p.1084-1092

2009

Volltextzugriff (PDF)

Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA

Journal of clinical virology, 2013-10, Vol.58 (2), p.401-407

2013

Volltextzugriff (PDF)

Efficacy of peginterferon alpha‐2b in chronic hepatitis delta: Relevance of quantitative RT‐PCR for follow‐up

Hepatology (Baltimore, Md.), 2006-09, Vol.44 (3), p.728-735

2006

Volltextzugriff (PDF)

Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: A prospective study

Hepatology (Baltimore, Md.), 2007-08, Vol.46 (2), p.380-387

2007

Volltextzugriff (PDF)

IFI35, mir-99a and HCV genotype to predict sustained virological response to pegylated-interferon plus ribavirin in chronic hepatitis C

PloS one, 2015-04, Vol.10 (4), p.e0121395-e0121395

2015

Volltextzugriff (PDF)

Hepatitis B surface antigen seroclearance: Immune mechanisms, clinical impact, importance for drug development

Journal of hepatology, 2020-08, Vol.73 (2), p.409-422

2020

Volltextzugriff (PDF)

Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B

Gastroenterology (New York, N.Y. 1943), 2002-12, Vol.123 (6), p.1812-1822

2002

Volltextzugriff (PDF)

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

The Lancet (British edition), 2019-04, Vol.393 (10179), p.1453-1464

2019

Volltextzugriff (PDF)

Impact of ribavirin dose on retreatment of chronic hepatitis C patients

World journal of gastroenterology : WJG, 2012-06, Vol.18 (23), p.2966-2972

2012

Volltextzugriff (PDF)

Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C, or nonalcoholic steatohepatitis

Hepatology (Baltimore, Md.), 2023-04, Vol.77 (4), p.1348-1365

2023

Volltextzugriff (PDF)

Un modèle de prévision de rendement de la canne à sucre basé sur des images satellitaires SPOT : l'exemple de la Réunion

Revue française de photogrammétrie et de télédétection, 2014-04 (197), p.76-85

2014

Volltextzugriff (PDF)

Future treatments for hepatitis delta virus infection

Liver international, 2020-02, Vol.40 (S1), p.54-60

2020

Volltextzugriff (PDF)

New therapies for hepatitis delta virus infection

Liver international, 2021-06, Vol.41 (S1), p.30-37

2021

Volltextzugriff (PDF)

Interferon Therapy for Chronic Hepatitis B

Clinics in liver disease, 2007-11, Vol.11 (4), p.839-849

2007

Volltextzugriff (PDF)

THU-194 - One year of HCV/HBV/HIV screening in a psychiatric population consulting in the emergency room (Beaujon Hol/REVHEPAT)

Journal of hepatology, 2023-06, Vol.78, p.S1193-S1194

2023

Volltextzugriff (PDF)

One year of HCV/HBV/HIV screening in a psychiatric population consulting in the emergency room (Beaujon Hol/REVHEPAT)

Journal of hepatology, 2023-06, Vol.78, p.S1193-S1194

2023

Volltextzugriff (PDF)

WED-159 - B cell phenotype, Toll-Like receptor 9 expression and proinflammatory cytokines profile in patients with chronic hepatitis B with HBsAg loss or persistent

Journal of hepatology, 2023-06, Vol.78, p.S1093-S1093

2023

Volltextzugriff (PDF)

B cell phenotype, Toll-Like receptor 9 expression and proinflammatory cytokines profile in patients with chronic hepatitis B with HBsAg loss or persistent

Journal of hepatology, 2023-06, Vol.78, p.S1093

2023

Volltextzugriff (PDF)

Diabetes mellitus is an independent prognostic factor for major liver‐related outcomes in patients with cirrhosis and chronic hepatitis C

Hepatology (Baltimore, Md.), 2014-09, Vol.60 (3), p.823-831

2014

Volltextzugriff (PDF)

1 – 25 von 449

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(399)
Mit Volltextzugriff
(396)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(412)
Französisch
(39)

Erscheinungsjahr

n.n

Thema

Science & Technology
(292)
Life Sciences & Biomedicine
(273)
Humans
(216)
Life Sciences
(143)
Female
(138)
Male
(135)
Adult
(111)
Middle Aged
(97)
Biological And Medical Sciences
(75)
Gastroenterology & Hepatology
(70)
Medical Sciences
(64)
Infectious Diseases
(54)
Aged
(53)
Human Health And Pathology
(42)
Patients
(36)
Animals
(34)
Antiviral Agents - Therapeutic Use
(34)
Mutation
(30)
Retrospective Studies
(30)
Hepatitis C, Chronic - Drug Therapy
(29)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives

Targets and future direct-acting antiviral approaches to achieve hepatitis B virus cure

Fibrosis and disease progression in hepatitis C

Potential of SAR sensors TerraSAR-X, ASAR/ENVISAT and PALSAR/ALOS for monitoring sugarcane crops on Reunion Island

Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa‐2a in HBeAg‐negative patients

Eradication of Hepatitis C Virus in Patients Successfully Treated for Chronic Hepatitis C

High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: A long-term follow-up study

Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA

Efficacy of peginterferon alpha‐2b in chronic hepatitis delta: Relevance of quantitative RT‐PCR for follow‐up

Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: A prospective study

IFI35, mir-99a and HCV genotype to predict sustained virological response to pegylated-interferon plus ribavirin in chronic hepatitis C

Hepatitis B surface antigen seroclearance: Immune mechanisms, clinical impact, importance for drug development

Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

Impact of ribavirin dose on retreatment of chronic hepatitis C patients

Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C, or nonalcoholic steatohepatitis

Un modèle de prévision de rendement de la canne à sucre basé sur des images satellitaires SPOT : l'exemple de la Réunion

Future treatments for hepatitis delta virus infection

New therapies for hepatitis delta virus infection

Interferon Therapy for Chronic Hepatitis B

THU-194 - One year of HCV/HBV/HIV screening in a psychiatric population consulting in the emergency room (Beaujon Hol/REVHEPAT)

One year of HCV/HBV/HIV screening in a psychiatric population consulting in the emergency room (Beaujon Hol/REVHEPAT)

WED-159 - B cell phenotype, Toll-Like receptor 9 expression and proinflammatory cytokines profile in patients with chronic hepatitis B with HBsAg loss or persistent

B cell phenotype, Toll-Like receptor 9 expression and proinflammatory cytokines profile in patients with chronic hepatitis B with HBsAg loss or persistent

Diabetes mellitus is an independent prognostic factor for major liver‐related outcomes in patients with cirrhosis and chronic hepatitis C

Suchergebnisse filtern